InsidersTradesSigma
Explore the full insider trade history of 우리바이오, a listed equity based in South Korea. Shares trade on KR KR, under the supervision of DART (FSS). Market capitalisation: €96.1bn. The latest transaction was reported on 7 April 2026 — Sale. Among the most active insiders: 우리바이오. Every trade is openly available.
FY ended December 2025 · cache
0 of 0 declarations